186 related articles for article (PubMed ID: 38380563)
1. N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease.
Guo T; Zhou L; Xiong M; Xiong J; Huang J; Li Y; Zhang G; Chen G; Wang ZH; Xiao T; Hu D; Bao A; Zhang Z
Aging Cell; 2024 May; 23(5):e14124. PubMed ID: 38380563
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of DJ-1/PARK7-Mediated Parkinson's Disease.
Skou LD; Johansen SK; Okarmus J; Meyer M
Cells; 2024 Feb; 13(4):. PubMed ID: 38391909
[TBL] [Abstract][Full Text] [Related]
3. The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress.
Oh SE; Park HJ; He L; Skibiel C; Junn E; Mouradian MM
Redox Biol; 2018 Oct; 19():62-73. PubMed ID: 30107296
[TBL] [Abstract][Full Text] [Related]
4. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
5. N-homocysteinylation of α-synuclein promotes its aggregation and neurotoxicity.
Zhou L; Guo T; Meng L; Zhang X; Tian Y; Dai L; Niu X; Li Y; Liu C; Chen G; Liu C; Ke W; Zhang Z; Bao A; Zhang Z
Aging Cell; 2023 Mar; 22(3):e13745. PubMed ID: 36437524
[TBL] [Abstract][Full Text] [Related]
6. Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease.
Dolgacheva LP; Berezhnov AV; Fedotova EI; Zinchenko VP; Abramov AY
J Bioenerg Biomembr; 2019 Jun; 51(3):175-188. PubMed ID: 31054074
[TBL] [Abstract][Full Text] [Related]
7. DJ-1 protects cell death from a mitochondrial oxidative stress due to GBA1 deficiency.
Nam Y; Na J; Ma SX; Park H; Park H; Lee E; Kim H; Jang SM; Ko HS; Kim S
Genes Genomics; 2024 May; 46(5):519-529. PubMed ID: 38460098
[TBL] [Abstract][Full Text] [Related]
8. Loss of DJ-1 function contributes to Parkinson's disease pathogenesis in mice via RACK1-mediated PKC activation and MAO-B upregulation.
Liu LL; Han Y; Zhang ZJ; Wang YQ; Hu YW; Kaznacheyeva E; Ding JQ; Guo DK; Wang GH; Li B; Ren HG
Acta Pharmacol Sin; 2023 Oct; 44(10):1948-1961. PubMed ID: 37225849
[TBL] [Abstract][Full Text] [Related]
9. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective function of DJ-1 in Parkinson's disease.
Ariga H; Takahashi-Niki K; Kato I; Maita H; Niki T; Iguchi-Ariga SM
Oxid Med Cell Longev; 2013; 2013():683920. PubMed ID: 23766857
[TBL] [Abstract][Full Text] [Related]
11. RNAi-mediated knockdown of DJ-1 leads to mitochondrial dysfunction via Akt/GSK-3ß and JNK signaling pathways in dopaminergic neuron-like cells.
Zhang XL; Wang ZZ; Shao QH; Zhang Z; Li L; Guo ZY; Sun HM; Zhang Y; Chen NH
Brain Res Bull; 2019 Mar; 146():228-236. PubMed ID: 30634017
[TBL] [Abstract][Full Text] [Related]
12. The Parkinson's Disease-Associated Protein DJ-1 Protects
Chen S; Annesley SJ; Jasim RAF; Fisher PR
Cells; 2021 Jul; 10(8):. PubMed ID: 34440642
[TBL] [Abstract][Full Text] [Related]
13. The Parkinson's Disease-Linked Protein DJ-1 Associates with Cytoplasmic mRNP Granules During Stress and Neurodegeneration.
Repici M; Hassanjani M; Maddison DC; Garção P; Cimini S; Patel B; Szegö ÉM; Straatman KR; Lilley KS; Borsello T; Outeiro TF; Panman L; Giorgini F
Mol Neurobiol; 2019 Jan; 56(1):61-77. PubMed ID: 29675578
[TBL] [Abstract][Full Text] [Related]
14. PARK7/DJ-1 in microglia: implications in Parkinson's disease and relevance as a therapeutic target.
Lind-Holm Mogensen F; Scafidi A; Poli A; Michelucci A
J Neuroinflammation; 2023 Apr; 20(1):95. PubMed ID: 37072827
[TBL] [Abstract][Full Text] [Related]
15. Astroglial DJ-1 over-expression up-regulates proteins involved in redox regulation and is neuroprotective in vivo.
Frøyset AK; Edson AJ; Gharbi N; Khan EA; Dondorp D; Bai Q; Tiraboschi E; Suster ML; Connolly JB; Burton EA; Fladmark KE
Redox Biol; 2018 Jun; 16():237-247. PubMed ID: 29525604
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease-related DJ-1 modulates the expression of uncoupling protein 4 against oxidative stress.
Xu S; Yang X; Qian Y; Xiao Q
J Neurochem; 2018 May; 145(4):312-322. PubMed ID: 29315581
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Activities of DJ-1 and Its Binding Compounds Against Neurodegenerative Diseases.
Inden M; Yanagisawa D; Hijioka M; Ariga H; Kitamura Y
Adv Exp Med Biol; 2017; 1037():187-202. PubMed ID: 29147910
[TBL] [Abstract][Full Text] [Related]
18. DJ-1 as a Biomarker of Parkinson's Disease.
Saito Y
Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
[TBL] [Abstract][Full Text] [Related]
19. DJ-1 modulates the unfolded protein response and cell death via upregulation of ATF4 following ER stress.
Yang J; Kim KS; Iyirhiaro GO; Marcogliese PC; Callaghan SM; Qu D; Kim WJ; Slack RS; Park DS
Cell Death Dis; 2019 Feb; 10(2):135. PubMed ID: 30755590
[TBL] [Abstract][Full Text] [Related]
20. Oxidative modification impairs SERCA activity in Drosophila and human cell models of Parkinson's disease.
Solana-Manrique C; Muñoz-Soriano V; Sanz FJ; Paricio N
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166152. PubMed ID: 33892078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
